Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NA17-A

Known as: NA17 A, NA17-A Antigen, NA17A 
A specific melanoma antigen protein derived from a patient (NA17) with cutaneous melanoma metastases. When administered in a vaccine formulation… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Genomic characterization of two Orf virus isolates from Jilin province in China
Orf virus (ORFV), a typical member of the Parapoxvirus genus within the family Poxviridae, which is the causative agent of Orf, a… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
2013
2013
High frequency of T cells specific for cryptic epitopes in melanoma patients
A number of cytotoxic T-cell epitopes are cryptic epitopes generated from non-conventional sources. These include epitopes that… Expand
Highly Cited
2006
Highly Cited
2006
Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients
Purpose: A phase I/II trial was conducted to evaluate clinical and immunologic responses after intralymphatic and intranodal… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2002
2002
Apoptotic body–loaded dendritic cells efficiently cross‐prime cytotoxic T lymphocytes specific for NA17‐A antigen but not for Melan‐A/MART‐1 antigen
DCs hold promise for cancer immunotherapy due to their functional ambivalence: iDCs internalize antigens, then mDCs trigger naive… Expand
1998
1998
Frequency and relative fraction of tumor antigen‐specific T cells among lymphocytes from melanoma‐invaded lymph nodes
Several tumor antigens have been described as candidates for immunotherapy. Our study compared HLA‐A2‐restricted epitopes from 5… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE